These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9593047)

  • 1. Biologic activity of oligonucleotides with polarity and anomeric center reversal.
    Tan TM; Kalisch BW; van de Sande JH; Ting RC; Tan YH
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):95-101. PubMed ID: 9593047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes.
    Tan TM; Ting RC
    Cancer Res; 1995 Oct; 55(20):4599-605. PubMed ID: 7553636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes.
    Tan TM; Gloss B; Bernard HU; Ting RC
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2663-70. PubMed ID: 7931152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of cervical tumor cells by antisense oligodeoxynucleotides directed to the human papillomavirus type 16 E6 gene.
    Alvarez-Salas LM; Arpawong TE; DiPaolo JA
    Antisense Nucleic Acid Drug Dev; 1999 Oct; 9(5):441-50. PubMed ID: 10555151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
    Belcastro M; Miller MR; Flynn DC; Soisson AP
    Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines.
    Steele C; Cowsert LM; Shillitoe EJ
    Cancer Res; 1993 May; 53(10 Suppl):2330-7. PubMed ID: 7683572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
    Choo CK; Ling MT; Suen CK; Chan KW; Kwong YL
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):293-301. PubMed ID: 10985883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of liposomal antisense oligonucleotides on mRNA and protein levels of the HPV 16 E7 oncogene.
    Lappalainen K; Pirilä L; Jääskeläinen I; Syrjänen K; Syrjänen S
    Anticancer Res; 1996; 16(5A):2485-92. PubMed ID: 8917339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
    Kunke D; Grimm D; Denger S; Kreuzer J; Delius H; Komitowski D; Kleinschmidt JA
    Cancer Gene Ther; 2000 May; 7(5):766-77. PubMed ID: 10830724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
    Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
    J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer.
    Peto M; Tolle-Ersü I; Kreysch HG; Klock G
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells.
    Hamada K; Sakaue M; Alemany R; Zhang WW; Horio Y; Roth JA; Mitchell MF
    Gynecol Oncol; 1996 Nov; 63(2):219-27. PubMed ID: 8910631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
    J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.